Secondary outcomes included mean change from baseline best-corrected visual acuity ( BCVA ) score , percentage of subjects who gained or lost greater than or equal to 15 letters of vision , percentage of subjects who are 20/40 or better , percentage of subjects who are 20/200 or worse , and the incidence of adverse events ( AE ) and serious AEs .